Mesolimbic NMDA receptors are implicated in the expression of conditioned morphine reward

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 359, Issue 4, 1999, Pages 288-294

  Popik, Piotr ^a   Kolasiewicz, Wacław ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Conditioned place preference; Morphine; NMDA receptor antagonists; Nucleus accumbens; Rats; Ventral tegmental area

Indexed keywords

2 AMINO 4,5 (1,2 CYCLOHEXYL) 7 PHOSPHONOHEPTANOIC ACID; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; HISTOLOGY; LIMBIC SYSTEM; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; RAT; VENTRAL TEGMENTUM;

EID: 0032899605     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005354     Document Type: Article

References (55)

1. Albin RL, Makowiec RL, Hollingsworth ZR, Dure LS, Penney JB, Young AB (1991) Excitatory amino acid binding sites in the basal ganglia of the rat: A quantitative autoradiographic study. Neuroscience 46:35-48
2. Bals-Kubik R, Ableitner A, Herz A, Shippenberg TS (1993) Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J Pharmacol Exp Ther 264:489-495
3. Bespalov A, Dumpis M, Piotrovsky L, Zvartau E (1994) Excitatory amino acid receptor antagonist kynurenic acid attenuates rewarding potential of morphine. Eur J Pharmacol 264:233-239
4. Bisaga A, Gianelli P, Popik P (1997) Opiate withdrawal using dextromethorphan. Am J Psychiatry 154:584
5. Bozarth MA (1987) Neuroanatomical boundaries of the reward-relevant opiate-receptor field in the ventral tegmental area as mapped by the conditioned place preference method in rats. Brain Res 414:77-84
6. Bozarth MA, Wise RA (1981) Intracranial self-administration of morphine into the ventral tegmental area. Life Sci 28:551-555
7. Broekkamp CL, Phillips AG (1979) Facilitation of self-stimulation behavior following intracerebral microinjections of opioids into the ventral tegmental area. Pharmacol Biochem Behav 11:289-295
8. Broekkamp CL, Van den Bogaard JH, Heijnen HJ, Rops RH, Cools AR, Van Rossum JM (1976) Separation of inhibiting and stimulating effects of morphine on self-stimulation behaviour by intracerebral microinjections. Eur J Pharmacol 36:443-446
9. Burns LH, Everitt BJ, Kelley AE, Robbins TW (1994) Glutamatedopamine interactions in the ventral striatum: Role in locomotor activity and responding with conditioned reinforcement. Psychopharmacology 115:516-528
10. Carr GF, Fibiger HC, Phillips AG (1989) Conditioned place preference as a measure of drug reward. In: Liebman J, Cooper SJ (eds) The Neuropharmacological Basis of Reward. Clarendon, Oxford, pp 264-319
11. Carter CJ (1982) Topographical distribution of possible glutamatergic pathways from the frontal cortex to the striatum and substantia nigra in rats. Neuropharmacology 21:379-383
12. Christie MF, Bridge S, James LB, Beart PM (1989) Excitotoxin lesions suggest an aspartatergic projection from rat medial prefrontal cortex to ventral tegmental area. Acta Physiol Scand 136:135-136
13. Clements JR, Toth D, Highfield DA, Grant SJ (1991) Glutamate-like immunoreactivity is present within cholinergic neurons of the laterodorsal tegmental and pedunculopontine nuclei. In: Napier TC, Kalivas PW, Hanin I (eds) The Basal Forebrain: Anatomy to Function. Plenum, New York, pp 127-142
14. Cotman CW, Monaghan DT, Ottersen OP, Storm-Mathisen J (1987) Anatomical organization of excitatory amino acid receptors and their pathways. Trends Neurosci 10:273-279
15. Delpozo E, Barrios M, Baeyens JM (1996) The NMDA receptor antagonist dizocilpine (MK-801) stereoselectively inhibits morphine induced place preference conditioning in mice. Psychopharmacology 125:209-213
16. Devine DP, Wise RA (1994) Self-administration of morphine, DAMGO and DPDPE into the ventral tegmental area of rats. J Neurosci 14:1978-1984
17. Ferkany JW, Hamilton GS, Patch RJ, Huang Z, Borosky SA, Bednar DL, Jones BE, Zubrowski R, Willetts J, Karbon EW (1993) Pharmacological profile of NPC 17742 [2R,4R,5S-(2-amino-4,5-(1,2-cyclohexyl)-7-phosphonoheptanoic acid)], a potent, selective and competitive N-methyl-D-aspartate receptor antagonist. J Pharmacol Exp Ther 264:256-264
18. Fuller TA, Russchen FT, Price JL (1987) Sources of presumptive glutamatergic/aspartergic afferents to the rat ventral striatopallidal region. J Comp Neurol 258:317-338
19. Goudie AJ (1991) Animal models of drug abuse and dependence. In: Willner P (ed) Behavioural Models in Psychopharmacology: Theoretical, Industrial and Clinical Perspectives. Cambridge University Press, Cambridge, pp 453-484
20. Herman BH, O'Brien CP (1997) Clinical medications development for opiate addiction: Focus on nonopioids and opioid antagonists for the amelioration of opiate withdrawal symptoms and relapse prevention. Semin Neurosci 9:158-172
21. Johnson SW, North RA (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12:483-488
22. Johnson SW, Seutin V, North RA (1992) Burst firing in dopamine neurons induced by N-methyl-D-aspartate: Role of electrogenic sodium pump. Science 258:665-667
23. Kalivas PW, Alesdatter JE (1993) Involvement of N-methyl-D-aspartare receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J Pharmacol Exp Ther 267:486-495
24. Kalivas PW, Stewart J (1991) Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev 16:223-244
25. Kelley AE, Throne LC (1992) NMDA receptors mediate the behavioral effects of amphetamine infused into the nucleus accumbens. Brain Res Bull 29:247-254
26. Kita H, Kitai ST (1986) Efferent projections of the subthalamic nucleus in the rat. Light and electron microscopic analysis with the PHA-L method. J Comp Neurol 372:21-30
27. Kelley AE, Domesick VB, Nauta WJH (1982) The amygdalostriatal projection in the rat - An anatomical study by anterograde and retrograde tracing methods. Neuroscience 7:615-626
28. Kolasiewicz W, Maj J (1996) Locomotor activity and motor disturbances induced by competitive NMDA receptor antagonist CGP 37849. Pol J Pharmacol 48:467-479
29. Koyuncuoglu H, Saydam B (1990) The treatment of heroin addicts with dextromethorphan. A double-blind comparison of dextromethorphan with chloropromazine. Int J Clin Pharmacol Ther Toxicol 28:147-152
30. Layer RT, Uretsky NJ, Wallace LJ (1993) Effects of the AMPA/kainate receptor antagonist DNQX in the nucleus accum-bens on drug-induced conditioned place preference. Brain Res 617:267-273
31. Leone P, Pocock D, Wise RA (1991) Morphine-dopamine interaction: Ventral tegmental morphine increases nucleus accumbens dopamine release. Pharmacol Biochem Behav 39:469-472
32. Moghaddam B, Bolinao ML (1994) Glutamatergic antagonists attenuate ability of dopamine uptake blockers to increase extracellular levels of dopamine: Implications for tonic influence of glutamate on dopamine release. Synapse 18:337-342
33. Monaghan DT, Cotman CW (1985) Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain. J Neurosci 5:2909-2919
34. Nestler EJ, Aghajanian GK (1997) Molecular and cellular basis of addiction. Science 278:58-63
35. Olds ME (1982) Reinforcing effects of morphine in the nucleus accumbens. Brain Res 237:429-440
36. Overton P, Clark D (1992) Iontophoretically administered drugs acting at the N-methyl-D-aspartate receptor modulate burst firing in A9 dopamine neurons in the rat. Synapse 10:131-140
37. Paxinos G, Watson C (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York
38. Phillips AG, LePiane FG (1980) Reinforcing effects of morphine microinjection into the ventral tegmental area. Pharmacol Biochem Behav 12:965-968
39. Phillips AG, LePiane FG, Fibiger HC (1983) Dopaminergic mediation of reward produced by different injection of enkephalin into the ventral tegmental area of the rat. Life Sci 33:2505-2511
40. Popik P, Danysz W (1997) Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by NMDA receptor antagonist, memantine. J Pharmacol Exp Ther 280:854-865
41. Popik P, Skolnick P (1996) The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence. Pharmacol Biochem Behav 53:791-798
42. Popik P, Mamczarz J, Fraczek M, Widla M, Hesselink M, Danysz W (1998) Inhibition of reinforcing effects of morphine and naloxone - Precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists. Neuropharmacology 37:1033-1042
43. Pulvirenti L, Swerdlow NR, Koob GF (1991) Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin or accumbens dopamine, but not caffeine. Pharmacol Biochem Behav 40:841-845
44. Robinson TG, Beart PM (1988) Excitant amino acid projections from rat amygdala and thalamus to nucleus accumbens. Brain Res Bull 20:467-471
45. Robledo P, Feger J (1990) Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: Electrophysiological data. Brain Res 518:47-54
46. Seutin V, Johnson SW, North RA (1994) Effect of dopamine and baclofen on N-methyl-D-aspartate-induced burst firing in rat ventral tegmental neurons. Neuroscience 58:201-206
47. Tzschentke TM, Schmidt WJ (1995) N-methyl-D-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats. Neurosci Lett 193:37-40
48. Tzschentke TM, Schmidt WJ (1997) Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitization. Behav Brain Res 84:99-107
49. Van der Kooy D, Mucha RF, O'Shaughnessy M, Bucenieks P (1982) Reinforcing effects of brain microinjections of morphine revealed by conditioned place preference. Brain Res 243:107-117
50. Walaas I (1981) Biochemical evidence for overlapping neocortical and allocortical glutamate projections to the nucleus accumbens and rostral caudatoputamen in the rat brain. Neuroscience 6:399-405
51. Walaas I, Fonnum F (1979) The effects of surgical and chemical lesions on neurotransmitter candidates in the nucleus accumbens of the rat. Neuroscience 4:209-216
52. Wang T, French ED (1993) Effects of phencyclidine on spontaneous and excitatory amino acid-induced activity of ventral tegmental dopamine neurons: An extracellular in vitro study. Life Sci 53:49-56
53. Wiley JL, Cristello AF, Balster RL (1995) Effects of site-selective NMDA receptor antagonists in an elevated plus-maze model of anxiety in mice. Eur J Pharmacol 294:101-107
54. Wise RA (1989) Opiate reward: Sites and substrates. Neurosci Biobehav Rev 13:129-133
55. Zhang J, Chiodo LA, Freeman AS (1992) Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons. Brain Res 590:153-163